News for Vivos Inc. (RDGL)

Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. ( RDGL) is pleased to announce the significant achievements of its IsoPet® Animal Cancer Division,

Richland, WA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- ”“ Vivos Inc. ( RDGL) proudly announces the initiation of its first human clinical trial for RadioGel® Preci

WELLINGTON, FL / ACCESSWIRE / December 17, 2024 / Cellev8 Nutrition Inc (OTC PINK:CELV), a pioneer in Superoxide Dismutase (SOD) based supplements, has announce

Richland WA N, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. Certifies new clinic for IsoPet therapy. NorthStar Vets -...

Vivos CEO Michael Korenko buys $5.6k in company stock

The Dow Jones index closed lower by over 600 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the compan...

Vivos Inc CEO buys $4675 worth of company stock

Richland WA, July 29, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. Provides IDE Submission Status Update The FDA has been working...

Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption...

Loading... Loading... The Dow Jones index closed higher by over 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or ...

CLARKSBURG., Maryland, March 07, 2024 (GLOBE NEWSWIRE) -- Reliability Incorporated OTC PINK (RLBY) On December 29, 2023, the Circuit Court for...

The Dow Jones closed lower by around 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

/PRNewswire/ -- DelveInsight's Sleep Aid Market Insights report provides the current and forecast market analysis, individual leading sleep aid companies'...

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.